ArticleArchives of osteoporosis2020

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark.

M Sanni Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.